Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
uL 34 36 34 36 I-lower_bound

Aspartate 0 9 37 46 B-clinical_variable
aminotransferase 10 26 47 63 I-clinical_variable
( 27 28 64 65 I-clinical_variable
AST 28 31 65 68 I-clinical_variable
) 31 32 68 69 I-clinical_variable
( 33 34 70 71 O
serum 34 39 71 76 B-clinical_variable
glutamic 40 48 77 85 I-clinical_variable
oxaloacetic 49 60 86 97 I-clinical_variable
transaminase 61 73 98 110 I-clinical_variable
[ 74 75 111 112 I-clinical_variable
SGOT])/alanine 75 89 112 126 I-clinical_variable
aminotransferase 90 106 127 143 I-clinical_variable
( 107 108 144 145 I-clinical_variable
ALT 108 111 145 148 I-clinical_variable
) 111 112 148 149 I-clinical_variable
( 113 114 150 151 O
serum 114 119 151 156 B-clinical_variable
glutamate 120 129 157 166 I-clinical_variable
pyruvate 130 138 167 175 I-clinical_variable
transaminase 139 151 176 188 I-clinical_variable
[ 152 153 189 190 I-clinical_variable
SGPT 153 157 190 194 I-clinical_variable
] 157 158 194 195 I-clinical_variable
) 158 159 195 196 O
< 160 161 197 198 O
2.5 162 165 199 202 B-upper_bound
X 166 167 203 204 I-upper_bound
institutional 168 181 205 218 I-upper_bound
upper 182 187 219 224 I-upper_bound
limit 188 193 225 230 I-upper_bound
of 194 196 231 233 I-upper_bound
normal 197 203 234 240 I-upper_bound

Creatinine 0 10 241 251 B-clinical_variable
= 11 12 252 253 O
< 12 13 253 254 O
1.5 14 17 255 258 B-upper_bound
mg 18 20 259 261 I-upper_bound
/ 20 21 261 262 I-upper_bound
dL 21 23 262 264 I-upper_bound
to 24 26 265 267 O
receive 27 34 268 275 O
weekly 35 41 276 282 O
cisplatin 42 51 283 292 B-treatment

Hemoglobin 0 10 293 303 B-clinical_variable
> 11 12 304 305 O
10 13 15 306 308 B-lower_bound
g 16 17 309 310 I-lower_bound
/ 17 18 310 311 I-lower_bound
dL 18 20 311 313 I-lower_bound

Patient 0 7 314 321 O
does 8 12 322 326 O
not 13 16 327 330 O
have 17 21 331 335 O
a 22 23 336 337 O
known 24 29 338 343 O
allergy 30 37 344 351 O
to 38 40 352 354 O
compounds 41 50 355 364 O
of 51 53 365 367 O
similar 54 61 368 375 O
or 62 64 376 378 O
biologic 65 73 379 387 O
composition 74 85 388 399 O
as 86 88 400 402 O
triapine 89 97 403 411 B-treatment

Patient 0 7 412 419 O
does 8 12 420 424 O
not 13 16 425 428 O
have 17 21 429 433 O
known 22 27 434 439 O
brain 28 33 440 445 B-cancer
metastases 34 44 446 456 I-cancer
( 45 46 457 458 O
testing 46 53 458 465 O
optional 54 62 466 474 O
) 62 63 474 475 O

Patient 0 7 476 483 O
does 8 12 484 488 O
not 13 16 489 492 O
have 17 21 493 497 O
known 22 27 498 503 O
glucose‐6‐phosphate 28 47 504 523 B-chronic_disease
dehydrogenase 48 61 524 537 I-chronic_disease
( 62 63 538 539 I-chronic_disease
G6PD 63 67 539 543 I-chronic_disease
) 67 68 543 544 I-chronic_disease
deficiency 69 79 545 555 I-chronic_disease
( 80 81 556 557 O
G6PD 81 85 557 561 O
testing 86 93 562 569 O
optional 94 102 570 578 O
) 102 103 578 579 O

Patient 0 7 580 587 O
does 8 12 588 592 O
not 13 16 593 596 O
have 17 21 597 601 O
known 22 27 602 607 O
human 28 33 608 613 B-chronic_disease
immunodeficiency 34 50 614 630 I-chronic_disease
virus 51 56 631 636 I-chronic_disease
syndrome 57 65 637 645 O
( 66 67 646 647 O
HIV 67 70 647 650 B-chronic_disease
, 70 71 650 651 O
testing 72 79 652 659 O
optional 80 88 660 668 O
) 88 89 668 669 O

Patient 0 7 670 677 O
does 8 12 678 682 O
not 13 16 683 686 O
have 17 21 687 691 O
uncontrolled 22 34 692 704 B-chronic_disease
diabetes 35 43 705 713 I-chronic_disease
mellitus 44 52 714 722 I-chronic_disease
( 53 54 723 724 O
i.e. 54 58 724 728 O
, 58 59 728 729 O
fasting 60 67 730 737 B-clinical_variable
blood 68 73 738 743 I-clinical_variable
glucose 74 81 744 751 I-clinical_variable
> 82 83 752 753 O
200 84 87 754 757 B-lower_bound
mg 88 90 758 760 I-lower_bound
/ 90 91 760 761 I-lower_bound
dL 91 93 761 763 I-lower_bound
) 93 94 763 764 O

Patient 0 7 765 772 O
has 8 11 773 776 O
a 12 13 777 778 O
life 14 18 779 783 B-clinical_variable
expectancy 19 29 784 794 I-clinical_variable
of 30 32 795 797 O
greater 33 40 798 805 O
than 41 45 806 810 O
20 46 48 811 813 B-lower_bound
weeks 49 54 814 819 I-lower_bound

Patient 0 7 820 827 O
has 8 11 828 831 O
a 12 13 832 833 O
new 14 17 834 837 O
, 17 18 837 838 O
unrated 19 26 839 846 O
histologic 27 37 847 857 O
diagnosis 38 47 858 867 O
of 48 50 868 870 O
stage 51 56 871 876 B-lower_bound
IB2 57 60 877 880 I-lower_bound
( 61 62 881 882 O
> 62 63 882 883 O
5 64 65 884 885 B-lower_bound
cm 66 68 886 888 I-lower_bound
) 68 69 888 889 O
, 69 70 889 890 O
II 71 73 891 893 O
, 73 74 893 894 O
IIIB 75 79 895 899 O
or 80 82 900 902 O
IVA 83 86 903 906 B-upper_bound
squamous 87 95 907 915 B-cancer
, 95 96 915 916 O
adenocarcinoma 97 111 917 931 B-cancer
, 111 112 931 932 O
or 113 115 933 935 O
adenosquamous 116 129 936 949 B-cancer
carcinoma 130 139 950 959 I-cancer
of 140 142 960 962 I-cancer
the 143 146 963 966 I-cancer
uterine 147 154 967 974 I-cancer
cervix 155 161 975 981 I-cancer
or 162 164 982 984 O
stage 165 170 985 990 B-lower_bound
II 171 173 991 993 I-lower_bound
- 173 174 993 994 O
IVA 174 177 994 997 O
squamous 178 186 998 1006 O
, 186 187 1006 1007 O
adenocarcinoma 188 202 1008 1022 O
, 202 203 1022 1023 O
or 204 206 1024 1026 O
adenosquamous 207 220 1027 1040 B-cancer
carcinoma 221 230 1041 1050 I-cancer
of 231 233 1051 1053 I-cancer
the 234 237 1054 1057 I-cancer
vagina 238 244 1058 1064 I-cancer
not 245 248 1065 1068 O
amenable 249 257 1069 1077 O
to 258 260 1078 1080 O
curative 261 269 1081 1089 B-treatment
surgical 270 278 1090 1098 I-treatment
resection 279 288 1099 1108 I-treatment
alone 289 294 1109 1114 O

Patient 0 7 1115 1122 O
has 8 11 1123 1126 O
another 12 19 1127 1134 O
concurrent 20 30 1135 1145 O
active 31 37 1146 1152 B-cancer
invasive 38 46 1153 1161 I-cancer
malignancy 47 57 1162 1172 I-cancer

Patient 0 7 1173 1180 O
has 8 11 1181 1184 O
had 12 15 1185 1188 O
a 16 17 1189 1190 O
prior 18 23 1191 1196 O
invasive 24 32 1197 1205 O
malignancy 33 43 1206 1216 B-cancer
diagnosed 44 53 1217 1226 O
within 54 60 1227 1233 O
the 61 64 1234 1237 O
last 65 69 1238 1242 B-upper_bound
three 70 75 1243 1248 I-upper_bound
years 76 81 1249 1254 I-upper_bound
( 82 83 1255 1256 O
except 83 89 1256 1262 O
[ 90 91 1263 1264 O
1 91 92 1264 1265 O
] 92 93 1265 1266 O
non 94 97 1267 1270 B-cancer
- 97 98 1270 1271 I-cancer
melanoma 98 106 1271 1279 I-cancer
skin 107 111 1280 1284 I-cancer
cancer 112 118 1285 1291 I-cancer
or 119 121 1292 1294 O
[ 122 123 1295 1296 O
2 123 124 1296 1297 O
] 124 125 1297 1298 O
prior 126 131 1299 1304 O
in 132 134 1305 1307 B-cancer
situ 135 139 1308 1312 I-cancer
carcinoma 140 149 1313 1322 I-cancer
of 150 152 1323 1325 I-cancer
the 153 156 1326 1329 I-cancer
cervix 157 163 1330 1336 I-cancer
) 163 164 1336 1337 O

Patient 0 7 1338 1345 O
has 8 11 1346 1349 O
uncontrolled 12 24 1350 1362 O
intercurrent 25 37 1363 1375 O
illness 38 45 1376 1383 O
including 46 55 1384 1393 O
, 55 56 1393 1394 O
but 57 60 1395 1398 O
not 61 64 1399 1402 O
limited 65 72 1403 1410 O
to 73 75 1411 1413 O
, 75 76 1413 1414 O
symptomatic 77 88 1415 1426 O
congestive 89 99 1427 1437 B-chronic_disease
heart 100 105 1438 1443 I-chronic_disease
failure 106 113 1444 1451 I-chronic_disease
, 113 114 1451 1452 O
unstable 115 123 1453 1461 B-chronic_disease
angina 124 130 1462 1468 I-chronic_disease
pectoris 131 139 1469 1477 I-chronic_disease
, 139 140 1477 1478 O
myocardial 141 151 1479 1489 B-chronic_disease
infarction 152 162 1490 1500 I-chronic_disease
within 163 169 1501 1507 O
six 170 173 1508 1511 B-upper_bound
months 174 180 1512 1518 I-upper_bound
of 181 183 1519 1521 O
protocol 184 192 1522 1530 O
initiation 193 203 1531 1541 O
, 203 204 1541 1542 O
cardiac 205 212 1543 1550 B-chronic_disease
arrhythmia 213 223 1551 1561 I-chronic_disease
within 224 230 1562 1568 O
six 231 234 1569 1572 O
months 235 241 1573 1579 O
of 242 244 1580 1582 O
protocol 245 253 1583 1591 O
initiation 254 264 1592 1602 O
; 264 265 1602 1603 O
known 266 271 1604 1609 O
inadequately 272 284 1610 1622 O
controlled 285 295 1623 1633 O
hypertension 296 308 1634 1646 B-chronic_disease
; 308 309 1646 1647 O
clinically 310 320 1648 1658 O
significant 321 332 1659 1670 O
pulmonary 333 342 1671 1680 B-chronic_disease
disease 343 350 1681 1688 I-chronic_disease
including 351 360 1689 1698 O
dyspnea 361 368 1699 1706 B-chronic_disease
at 369 371 1707 1709 O
rest 372 376 1710 1714 O
, 376 377 1714 1715 O
or 378 380 1716 1718 O
patients 381 389 1719 1727 O
requiring 390 399 1728 1737 O
supplemental 400 412 1738 1750 O
oxygen 413 419 1751 1757 O
, 419 420 1757 1758 O
or 421 423 1759 1761 O
poor 424 428 1762 1766 O
pulmonary 429 438 1767 1776 O
reserve 439 446 1777 1784 O
; 446 447 1784 1785 O
proteinuria 448 459 1786 1797 B-chronic_disease
or 460 462 1798 1800 O
clinically 463 473 1801 1811 O
significant 474 485 1812 1823 O
renal 486 491 1824 1829 B-chronic_disease
function 492 500 1830 1838 I-chronic_disease
impairment 501 511 1839 1849 I-chronic_disease
( 512 513 1850 1851 O
baseline 513 521 1851 1859 B-clinical_variable
serum 522 527 1860 1865 I-clinical_variable
creatinine 528 538 1866 1876 I-clinical_variable
> 539 540 1877 1878 O
2 541 542 1879 1880 B-lower_bound
mg 543 545 1881 1883 I-lower_bound
/ 545 546 1883 1884 I-lower_bound
dL 546 548 1884 1886 I-lower_bound
) 548 549 1886 1887 O
; 549 550 1887 1888 O
or 551 553 1889 1891 O
psychiatric 554 565 1892 1903 B-chronic_disease
illness 566 573 1904 1911 I-chronic_disease
/ 573 574 1911 1912 O
social 574 580 1912 1918 O
situations 581 591 1919 1929 O
that 592 596 1930 1934 O
would 597 602 1935 1940 O
limit 603 608 1941 1946 O
compliance 609 619 1947 1957 O
with 620 624 1958 1962 O
study 625 630 1963 1968 O
requirements 631 643 1969 1981 O

Patient 0 7 1982 1989 O
is 8 10 1990 1992 O
currently 11 20 1993 2002 B-pregnancy
pregnant 21 29 2003 2011 I-pregnancy

Patient 0 7 2012 2019 O
is 8 10 2020 2022 O
not 11 14 2023 2026 O
actively 15 23 2027 2035 O
breastfeeding 24 37 2036 2049 O
( 38 39 2050 2051 O
or 39 41 2051 2053 O
has 42 45 2054 2057 O
agreed 46 52 2058 2064 O
to 53 55 2065 2067 O
discontinue 56 67 2068 2079 O
breastfeeding 68 81 2080 2093 O
before 82 88 2094 2100 O
the 89 92 2101 2104 O
initiation 93 103 2105 2115 O
of 104 106 2116 2118 O
protocol 107 115 2119 2127 O
therapy 116 123 2128 2135 B-treatment
) 123 124 2135 2136 O

Patient 0 7 2137 2144 O
is 8 10 2145 2147 O
receiving 11 20 2148 2157 O
another 21 28 2158 2165 O
investigational 29 44 2166 2181 B-treatment
agent 45 50 2182 2187 I-treatment
for 51 54 2188 2191 O
the 55 58 2192 2195 O
treatment 59 68 2196 2205 B-treatment
of 69 71 2206 2208 O
cancer 72 78 2209 2215 B-cancer

Patient 0 7 2216 2223 O
must 8 12 2224 2228 O
have 13 17 2229 2233 O
a 18 19 2234 2235 O
Gynecologic 20 31 2236 2247 B-clinical_variable
Oncology 32 40 2248 2256 I-clinical_variable
Group 41 46 2257 2262 I-clinical_variable
( 47 48 2263 2264 I-clinical_variable
GOG 48 51 2264 2267 I-clinical_variable
) 51 52 2267 2268 I-clinical_variable
performance 53 64 2269 2280 I-clinical_variable
status 65 71 2281 2287 I-clinical_variable
of 72 74 2288 2290 O
0 75 76 2291 2292 B-lower_bound
, 76 77 2292 2293 O
1 78 79 2294 2295 O
, 79 80 2295 2296 O
or 81 83 2297 2299 O
2 84 85 2300 2301 B-upper_bound
or 86 88 2302 2304 O
equivalent 89 99 2305 2315 O

Patients 0 8 2316 2324 O
scheduled 9 18 2325 2334 O
to 19 21 2335 2337 O
be 22 24 2338 2340 O
treated 25 32 2341 2348 O
with 33 37 2349 2353 O
adjuvant 38 46 2354 2362 B-treatment
consolidation 47 60 2363 2376 I-treatment
chemotherapy 61 73 2377 2389 I-treatment
at 74 76 2390 2392 O
the 77 80 2393 2396 O
conclusion 81 91 2397 2407 O
of 92 94 2408 2410 O
their 95 100 2411 2416 O
standard 101 109 2417 2425 O
chemoradiation 110 124 2426 2440 B-treatment

Patients 0 8 2441 2449 O
who 9 12 2450 2453 O
have 13 17 2454 2458 O
had 18 21 2459 2462 O
a 22 23 2463 2464 O
hysterectomy 24 36 2465 2477 B-treatment
or 37 39 2478 2480 O
are 40 43 2481 2484 O
planning 44 52 2485 2493 O
to 53 55 2494 2496 O
have 56 60 2497 2501 O
an 61 63 2502 2504 O
adjuvant 64 72 2505 2513 B-treatment
hysterectomy 73 85 2514 2526 I-treatment
following 86 95 2527 2536 O
radiation 96 105 2537 2546 B-treatment
as 106 108 2547 2549 O
part 109 113 2550 2554 O
of 114 116 2555 2557 O
their 117 122 2558 2563 O
cervical 123 131 2564 2572 B-treatment
cancer 132 138 2573 2579 I-treatment
treatment 139 148 2580 2589 I-treatment

Patients 0 8 2590 2598 O
with 9 13 2599 2603 O
self 14 18 2604 2608 O
- 18 19 2608 2609 O
reported 19 27 2609 2617 O
or 28 30 2618 2620 O
known 31 36 2621 2626 O
diagnosis 37 46 2627 2636 O
of 47 49 2637 2639 O
G6PD 50 54 2640 2644 B-chronic_disease
deficiency 55 65 2645 2655 I-chronic_disease

Platelets 0 9 2656 2665 B-clinical_variable
> 10 11 2666 2667 O
100,000 12 19 2668 2675 B-lower_bound
/ 19 20 2675 2676 I-lower_bound
uL 20 22 2676 2678 I-lower_bound

Prothrombin 0 11 2679 2690 B-clinical_variable
time 12 16 2691 2695 I-clinical_variable
( 17 18 2696 2697 I-clinical_variable
PT)/activated 18 31 2697 2710 I-clinical_variable
partial 32 39 2711 2718 I-clinical_variable
thromboplastin 40 54 2719 2733 I-clinical_variable
time 55 59 2734 2738 I-clinical_variable
( 60 61 2739 2740 I-clinical_variable
aPTT 61 65 2740 2744 I-clinical_variable
) 65 66 2744 2745 I-clinical_variable
< 67 68 2746 2747 O
1.5 69 72 2748 2751 B-upper_bound
X 73 74 2752 2753 I-upper_bound
institutional 75 88 2754 2767 I-upper_bound
upper 89 94 2768 2773 I-upper_bound
limit 95 100 2774 2779 I-upper_bound
of 101 103 2780 2782 I-upper_bound
normal 104 110 2783 2789 I-upper_bound

Total 0 5 2790 2795 B-clinical_variable
bilirubin 6 15 2796 2805 I-clinical_variable
< 16 17 2806 2807 O
2.0 18 21 2808 2811 B-upper_bound
mg 22 24 2812 2814 I-upper_bound
/ 24 25 2814 2815 I-upper_bound
dL 25 27 2815 2817 I-upper_bound

if 0 2 2818 2820 O
they 3 7 2821 2825 O
have 8 12 2826 2830 O
received 13 21 2831 2839 O
prior 22 27 2840 2845 B-treatment
pelvic 28 34 2846 2852 I-treatment
radiotherapy 35 47 2853 2865 I-treatment
for 48 51 2866 2869 O
any 52 55 2870 2873 O
reason 56 62 2874 2880 O
that 63 67 2881 2885 O
would 68 73 2886 2891 O
contribute 74 84 2892 2902 O
radiation 85 94 2903 2912 B-treatment
dose 95 99 2913 2917 O
that 100 104 2918 2922 O
would 105 110 2923 2928 O
exceed 111 117 2929 2935 O
tolerance 118 127 2936 2945 O
of 128 130 2946 2948 O
normal 131 137 2949 2955 O
tissues 138 145 2956 2963 O
at 146 148 2964 2966 O
the 149 152 2967 2970 O
discretion 153 163 2971 2981 O
of 164 166 2982 2984 O
the 167 170 2985 2988 O
treating 171 179 2989 2997 O
physician 180 189 2998 3007 O

known 0 5 3008 3013 O
HIV 6 9 3014 3017 B-chronic_disease
- 9 10 3017 3018 O
positive 10 18 3018 3026 O
patients 19 27 3027 3035 O
receiving 28 37 3036 3045 O
combination 38 49 3046 3057 B-treatment
antiretroviral 50 64 3058 3072 I-treatment
therapy 65 72 3073 3080 I-treatment

the 0 3 3081 3084 O
patient 4 11 3085 3092 O
must 12 16 3093 3097 O
be 17 19 3098 3100 O
able 20 24 3101 3105 O
to 25 27 3106 3108 O
tolerate 28 36 3109 3117 O
imaging 37 44 3118 3125 O
requirements 45 57 3126 3138 O
of 58 60 3139 3141 O
an 61 63 3142 3144 O
18F‐FDG 64 71 3145 3152 B-treatment
PET 72 75 3153 3156 I-treatment
/ 75 76 3156 3157 O
CT 76 78 3157 3159 B-treatment
scan 79 83 3160 3164 I-treatment

the 0 3 3165 3168 O
presence 4 12 3169 3177 O
or 13 15 3178 3180 O
absence 16 23 3181 3188 O
of 24 26 3189 3191 O
para‐aortic 27 38 3192 3203 B-cancer
lymph 39 44 3204 3209 I-cancer
node 45 49 3210 3214 I-cancer
metastasis 50 60 3215 3225 I-cancer
will 61 65 3226 3230 O
be 66 68 3231 3233 O
based 69 74 3234 3239 O
on 75 77 3240 3242 O
pre 78 81 3243 3246 B-treatment
- 81 82 3246 3247 I-treatment
therapy 82 89 3247 3254 I-treatment
18F‐FDG 90 97 3255 3262 I-treatment
PET 98 101 3263 3266 I-treatment
/ 101 102 3266 3267 I-treatment
CT 102 104 3267 3269 I-treatment

